Treating Cancers and Other Diseases Based on Its Flavivirus Technology Platform.
Top Scientific Team · Former FDA and CDE(NMPA, China) experts · Senior virologist in the Flavivirus field · The only global R&D team in the Flavivirus industry
Ancocare's Double-Spear products also have a mechanism of targeted activation of the immune system, which effectively solves the bottleneck of the immunity of existing treatment options and achieves broad-spectrum anti tumor capability.
DS1-H2-1 is in Progress of the Investigator Initiated Trial
Senior virologist in the Flavivirus filed. Dedicated expert team with scientific management.
a
n
c
o
c
a
r
e
